
“Data is our currency” – with Ginkgo Datapoints’ John Andros...
Successful use of AI is becoming a key differentiator for pharma companies.
Newsletters and Deep Dive digital magazine
Successful use of AI is becoming a key differentiator for pharma companies.
In an era marked by rapid technological advancements and evolving healthcare needs, the European Medicines Agencies Network Strategy 2028 stands as a key document.
At the heart of every pharma company lies a big problem: medical affairs and commercial teams are independently creating the same content.
The use of AI outcome prediction models (OPMs) in medicine is on the rise, but a new paper has warned widespread use could lead to patient harm.
A new AI-powered solution from EVERSANA aims to take the pain out of medical, legal and regulatory (MLR) reviews.
Editor's Picks
Newsletters and Deep Dive
digital magazine